An early cellular event in the development of psoriatic lesions is the infiltration of the target tissue by macrophages and activated T lymphocytes (8-10). Lesional psoriatic skin contains activated memory T lymphocytes ( 10-15 ) whose production of mRNA for lymphokines such as IL-2, y-IFN, and TNF-a is elevated relative to normal or uninvolved psoriatic epidermis (16) . That the T cell activation and soluble lymphokine production plays a crucial role in the maintenance of epidermal hyperplasia in the psoriatic lesion is indicated by the beneficial clinical effect of such immunosuppressive agents as cyclosporin A, FK 506, anti-CD3, and anti-CD4 in the treatment of psoriasis (17) (18) (19) (20) (21) (22) . Psoriatic keratinocytes do appear to have been modulated by T cell lymphokines in vivo, because they abnormally express class II MHC and IP-IO molecules uniquely induced on keratinocytes by the T cell product y-IFN (23-27). Indeed, T cells producing y-IFN have been cloned from psoriatic lesions (28) and they appear to be able to induce keratinocyte class II MHC and intracellular adhesion molecule expression (29) + 50 U/ml rIL-2 (Collaborative Biomedical Products) media in 24-well plates and then stimulated with PHA (lIg/ml) and allogeneic MNCs (0.5 x 106/well). After 48 h the MNCs were removed from the cultures by Ficoll-Hypaque density gradient centrifugation. 10-12 d were required for the T cells to reach resting state after PHA plus MNC activation, at which time they were then plated on fibronectin and anti-CD3-coated culture dishes in serum-free and IL-2-free AIM V media. Before cell plating the culture plates were coated initially with anti-CD3 (1 Mzg/ml) overnight 40C, washed with PBS (Gibco Laboratories) and then coated with fibronectin (Sigma Chemical Co.) (20 Yg/ ml) overnight 40C and washed with PBS, as previously described (36).
Go into G, of the cell cycle (PCNA expression), which preceded bright fl1 integrin expression. (fl1 integrinbriot ex- pression has been shown to be a characteristic feature of keratinocyte stem cells in culture (Jones, P. H., and F. M. Watt. 1993 . CeU. 73:713-724). Using the above assay, we determined whether lesional T lymphocytes in psoriasis could be directly responsible for the induction of the stem cell hyperproliferation that is characteristic of this disease. Indeed, CD4 + T lymphocytes, cloned from lesional psoriatic skin and stimulated by immobilized anti-CD3 plus fibronectin, promoted psoriatic uninvolved keratinocyte stem cell proliferation via soluble factors. This induction appeared to be through accelerated recruitment of stem cells from their quiescent state (Go) into cell cycle. By contrast, normal keratinocyte stem cells exhibited no such growth stimulation. Supernatants exhibiting growth induction all contained high levels of GM-CSF and r-IFN, low IL-3 and TNF-cx, and variable IL-4. Only anti-y-IFN antibody was able to neutralize growth stimulatory activity of the supernatants on psoriatic uninvolved keratinocyte stem cells. However, because recombinant y-IFN alone inhibited growth in this assay, these data suggest that, in psoriasis, y-IFN acts cooperatively with other growth factors in the immune induction of cell cycle progression by the normally quiescent stem cell keratinocytes. (J. Clin. Invest. 1995. 95:317-327.) Key words: .l1 integrin -keratin 1/keratin 10 *Vy-IFN -proliferating cell nuclear antigen * flow cytometry Recent progress in the identification and understanding of epidermopoietic subsets has highlighted the ability of normally slow cycling stem cells to increase their proliferation and generation of differentiating progeny in response to appropriate signals (1) (2) (3) . We have previously defined different subsets of proliferative cells in the in vivo human epidermis based on multiparameter flow cytometric analysis using specific antibodies related to cell differentiation (p61 integrin, KI /K10 keratins) and cell cycle (proliferating cell nuclear antigen [PCNA]'), in combination with flow cytometric quantitation of cellular DNA content and optical characteristics of the cells (4) . The 631 integrin marked both of the potentially proliferative subsets in normal epidermis.
One subset was 61 integrin+ Ki /K10-and contained basal keratinocytes. By all current definitions, the keratinocyte stem cell population must be contained within this /31 integrin+ Ki / K10-population. This population in the normal epidermis is slow cycling with more than 95% of them in Go phase (PCNA -) (4), a widely accepted feature of stem cells (5) . Cells in this population do not express Ki/K1O keratins, one of the first signs of differentiation in keratinocytes, indicating that they are in an undifferentiated state, another accepted criteria of stem cells (6, 7) . The /1 integrin+ K1/K10-population is a homogeneous population that is small in cell size and simple in cytoplasmic structure (4) . This population is similar to the stem cell population in human epidermis described by Lavker and Sun (6) which is small, nonserrated, slowly cycling, and primitive in cytoplasmic structure.
The other proliferative subset of normal epidermis was PI integrin+ Ki/K1O , this population was basal, slightly suprabasal, and contained highly proliferative, larger cells with more complex cytoplasmic structure, which is the phenotype characteristic of cells in in vivo epidermis which have committed to differentiation (K1/K10 expression) but undergo a transient period of proliferation before terminal differentiation (transient amplifying cells).
An in vivo human disease state in which normally slowly cycling epidermal progenitors hyperproliferate is psoriasis. In this state, the /31 integrin+ Kl /K1 0-stem cell-containing population has emerged from its normal Go state into virtually 100% active cell cycle status (4) . Understanding the signals for this dramatic shift into cell cycle may provide important information on stem cell physiology and pathophysiology, and may also yield therapeutic application in psoriasis.
An early cellular event in the development of psoriatic lesions is the infiltration of the target tissue by macrophages and activated T lymphocytes (8) (9) (10) . Lesional psoriatic skin contains activated memory T lymphocytes ( 10-15 ) whose production of mRNA for lymphokines such as IL-2, y-IFN, and TNF-a is elevated relative to normal or uninvolved psoriatic epidermis (16) . That the T cell activation and soluble lymphokine production plays a crucial role in the maintenance of epidermal hyperplasia in the psoriatic lesion is indicated by the beneficial clinical effect of such immunosuppressive agents as cyclosporin A, FK 506, anti-CD3, and anti-CD4 in the treatment of psoriasis (17) (18) (19) (20) (21) (22) . Psoriatic keratinocytes do appear to have been modulated by T cell lymphokines in vivo, because they abnormally express class II MHC and IP-IO molecules uniquely induced on keratinocytes by the T cell product y-IFN (23) (24) (25) (26) (27) . Indeed, T cells producing y-IFN have been cloned from psoriatic lesions (28) and they appear to be able to induce keratinocyte class II MHC and intracellular adhesion molecule expression (29) and growth of keratinocytes which have been multiply passaged in vitro (30 24- well plates and then stimulated with PHA (lIg/ml) and allogeneic MNCs (0.5 x 106/well). After 48 h the MNCs were removed from the cultures by Ficoll-Hypaque density gradient centrifugation. 10-12 d were required for the T cells to reach resting state after PHA plus MNC activation, at which time they were then plated on fibronectin and anti-CD3-coated culture dishes in serum-free and IL-2-free AIM V media. Before cell plating the culture plates were coated initially with anti-CD3 (1 Mzg/ml) overnight 40C, washed with PBS (Gibco Laboratories) and then coated with fibronectin (Sigma Chemical Co.) (20 Yg/ ml) overnight 40C and washed with PBS, as previously described (36) .
Supernatants were collected 48 h after plating, sterile filtered, and stored at -70TC. Lymphokine production by activated lesional psoriatic T cells was determined by using ELISA kits for GM-CSF, IL-3, IL-4 (R&D Systems, Inc., Minneapolis, MN), y-interferon (Genzyme Corp., Boston, MA) and TNF-a (PharMingen, San Diego, CA).
Clonal growth assay. Epidermal cell suspensions were prepared from normal and uninvolved psoriatic keratomes as described above. Cells were plated into 6-well culture plates (1 x 106 cells/ml, 2 ml/ well) in KBM (Gibco Laboratories) media supplemented with I1%FBS.
Activated T cell supernatants and AIM V media, as control, were diluted at 1:10 with KBM and added at the time of culture initiation to the cultures (200 pl/well). The media was changed on every third day, each time supplemented with activated T cell supernatant or AIM V media as described. After 2 wk plates were fixed with 1% formalin and stained with Rhodamine B (Sigma Chemical Co.) (37).
Short-term epidermal proliferation assay. Freshly isolated psoriatic uninvolved and normal epidermal cells were plated in 6-well culture plates at 1 x 106 cells/ml, 2 ml/well, and cultured for 72 h in the presence of activated psoriatic T cell supernatant (4F4, 4F1) or AIM V medium diluted 1:100 in KBM + 1% FBS. Cells were then fixed in 70% ethanol and stained with anti-/6l integrin, anti-K1/KlO, and antivimentin as above. DNA content was determined by staining with propidium iodide. Samples were analyzed by flow cytometry.
Neutralization experiments. In some experiments, lymphokines in the psoriatic activated T cell supernatants were neutralized with monoclonal antibodies. The following neutralizing antibodies were separately added to the epidermal cell cultures before addition of the activated T cell supernatant (4F4): mouse anti-human IFNy (Genzyme Corp.), 4 .5 Mg/ml; goat anti-human IL-3, 3 Mg/ml; goat anti-human GM-CSF (both from R&D Systems, Inc.), 20 ,ug/ml; mouse anti-human TNF-a (Boehringer Mannheim), 10 Mg/ml. Isotype controls were mouse IgG2a and IgG1 (Sigma Chemical Co.) and goat IgG (R&D Systems, Inc.), at identical concentrations. The concentrations were calculated to achieve a 100-fold excess of neutralizing activity based upon the known amounts of lymphokines in the supernatants and the neutralizing activity of each antibodies.
The above described short-term epidermal cell proliferation assay was used to test the effect of human recombinant y-IFN (Collaborative Biomedical Products, at 10 and 100 U/ml) on keratinocyte stem cells.
Statistical analysis. Pairwise Student's t test was used to compare keratinocyte stem cell growth in the presence of T cell supernatant and control media in the short-term proliferation assays.
Results
The /1 integrin + Kl/KIO-stem cell-containing keratinocyte subset is responsible for establishing colonies in primary in vitro cultures of human epidermal keratinocytes. Normal fresh ex vivo epidermal cells were plated in KBM + 1% FBS, and at different time points the cells were harvested and stained with anti-,61 integrin, anti-KlI/K0, and propidium iodide (PI).
At 24 h, the cultured cells exhibited characteristics by flow cytometry identical to freshly isolated cells ( Fig. 1 a) (4) . As compared to the isotype control-stained preparation ( Fig. 1 a, third column), essentially all proliferating cells were /31 integrin+ ( Fig. 1 a, first column, y axis) (S/G2/M phase is indicated along the x axis by cells with greater than diploid DNA content by PI intensity).
These /(1 integrin' cells at 24 h can be divided into two proliferating cell populations by Kl /KO0 expression ( Fig. 1 a, second column, y axis); (a) Kl/K1O-cells containing the cycling compartment of the stem cell population (a minor S/ G2/M population that lies below the horizontal cursor denoting positive/negative fluorescence) and (b) Kl /KlO + cells representing the transient amplifying cell population which has committed to differentiation in vivo but is still capable of proliferation (major population of cells in S/G2/M phase above the cursor).
After 72 h of culture, a distinct proliferating cell population begins to appear in the cultures, which has very bright,/1 integrin expression ( Fig. 1 Keratinocyte colony formation in vitro can be regulated by the soluble products of T lymphocytes; growth regulatory effect correlates with the lymphokine profile of cloned psoriatic lesional T cell subsets. Early psoriatic lesions were cultured in low concentration of IL-2 to propagate and clone in vivo-activated T cells expressing high affinity IL-2 receptors. After cloning, T cells were plated on anti-CD3-and fibronectin-coated tissue culture dishes in serum-free media. In initial experiments, activated T cell supernatants from 12 different lesional T cell clones were screened by measuring their effect on freshly isolated epidermal cell colony formation in vitro (Fig. 2) . At onstrated at the clonal level in lesional psoriasis ( 15, 29) , and the nature of the heterogeneity includes the capacity to be either growth promoting or growth inhibitory for keratinocytes. Interestingly, 75% of clones exhibited a positive growth-promoting Although conditions of T cell activation in the skin can result in epidermal hyperplasia in nonpsoriatic individuals (i.e., chronic dermatitis or tuberculoid leprosy [ 38 ] ), the hyperplasia in psoriatic subjects is more intense and sustained, suggesting a hyperresponsive state. We therefore compared the hyperplastic response of psoriatic uninvolved keratinocyte stem cells to epidermal stem cells from normals (n = 6). In contrast to the increased stem cell numbers appearing in cultures of psoriatic uninvolved cells, we could not detect lesional T cell induction of increased numbers of /1 integrinbnght cell population in epidermal cell cultures from normal individuals (Fig. 3, P (Fig. 4) . Thus, T cell lymphokines increase cycling among the culture-initiating keratinocytes of stem cell phenotype ( 1). Furthermore, in keeping with the cell number data, and in contrast to psoriasis, epidermal cell cultures from normals did not exhibit an increase in the S/ G2/M phase /1 integrinbflght population in response to T cell stimulation ( Fig. 4, P (Figs. 5 and 6 ). (Fig. 5 B) . (Fig. 6, A and B upper circles) . Increased cell numbers of the PCNA + 61 integrin + and PCNA bnght /31 integrinbnrht populations were detectable in T cell supernatant-treated (Fig. 6 A) relative to control media-containing cultures (Fig. 6 B) . The total PCNA + population comprised 23.2% vs. 13 .7% of 72-h cultured epidermal cells, respectively, and the /31 integrinbngh' and PCNAbnght subset comprised 4.5% of the T cell-stimulated culture as compared to 2.9% of the control media-treated culture (Fig. 6, A vs These data suggest that the growth-promoting effect of the lesional T cell supernatant is due to accelerated recruitment of /31 integrin + stem cells into GI and that cell cycle entry (PCNA expression) precedes the marked upregulation of /1 integrin which occurs among the clonogenic stem cells as they establish the culture. The very bright PCNA expression among the /31 integrinbnght cells likely indicates a build-up of PCNA protein during repeated, relatively rapid rounds of cell cycle (35) , whereas the /1 + PCNA + population's expansion may represent further stem cell recruitment.
Lesional psoriatic T cell lymphokines preferentially enhance /31 integrin+ keratinocyte growth over /31 integrin + melanocytes and Langerhans cells. Epidermal cell cultures in KBM + 1% FBS media consist mainly (> 95%) of keratinocytes; however, it is possible that melanocytes and Langerhans cells may proliferate in cultures stimulated by T cells. Like the keratinocyte stem cell-containing population, melanocytes and Langerhans cells are also /1 integrin+ Ki/K1O-in in vivo epidermis (4, 43, 44) . Therefore it was important to determine whether melanocytes or Langerhans cells are present in the /1 integrinbnight Ki /K1 0-population in the short-term cultures and to quantitate their contribution to the enhanced proliferation of the /31 integrinbMght KI/K1O-population after exposure to lesional psoriatic T cell supernatant. This was accomplished by costaining short-term cultured psoriatic uninvolved epidermal cells with anti-/I3 integrin plus anti-vimentin monoclonal antibodies. (Anti-vimentin stains Langerhans cells, melanocytes, and infiltrating lymphoid cells in the epidermis [44] .)
As expected, after 72 h, vimentin + cells were found in the culture; moreover, almost all exhibited /31 integrin bright expression (Fig. 7, quadrants 2 * T cells expanded in low dose IL-2 from untreated expanding psoriatic papule were cloned by limiting dilution and screened for keratinocyte clonal growth regulatory activity. T cells were phenotyped by dual color flow cytometry. § Keratinocyte clonal growth in KBM+1% FBS/1% Aim V media was assessed after addition of 48 h supernatants derived from anti-CD3+ fibronectin-stimulated T-cells. Relative to Aim V media control, growth promotion was scored as + if repeated experiments demonstrated an increase in colony density and size. Growth inhibition was scored as -if reduced colony density and size was observed. 11 Lymphokine levels in the 48-h stimulated T cell supernatants were determined by ELISA. NT, not tested.
treated culture (Fig. 7) expression of the T cells as well as differential lymphokine production. Our finding that certain cloned lesional psoriatic T cells induced enhanced keratinocyte clonal growth, whereas others inhibited growth provided an opportunity to examine whether distinct "growth stimulatory" lymphokine profiles could be identified. To answer this question we have measured, by ELISA, the IL-3, IL-4, GM-CSF, TNF-a, and gamma-interferon levels in the activated lesional psoriatic T cell supernatants. High GM-CSF (10-11 ng/ml) and y-IFN (38-51 ng/ ml) levels were characteristic of the growth stimulatory (upper group, Table II), and some of the growth inhibitory (lower group, Table II) T cell supernatants. Growth inhibition correlated with high IL-3 (32-34 ng/ml) and moderate TNF-a (2.6-6.8 ng/ml) levels, whereas growth stimulatory supernatants contained < 3 ng/ml IL-3 and < 1.5 ng/ml TNF-a. No obvious connection was found between cell growth and IL-4 levels; with most of the T cells producing substantial levels of both y-IFN and IL-4, only three exhibiting a type I lymphokine profile (high y-IFN, absent or very low IL-4), and none exhibiting a type II profile (low y-IFN, high IL-4) (Table II) . Thus, enhanced keratinocyte growth can not be obviously associated with high levels of any of the tested lymphokines. However, phenotypic analysis of the T cells revealed that growth stimulatory lymphokine production was exclusively mediated by CD4 + T cells, whereas T cells producing the inhibitory supernatants that were stained were composed of CD4-CD3+ T cells that contained CD8 + cells and CD8 -cells, but which all expressed a, / T cell receptor (TCR) and not y, 6 TCR (Table II) .
Lesional T cell stimulation of psoriatic keratinocyte stem cell hyperproliferation is multifactorial, y-IFN appears to be a critical component for growth stimulation, but requires the presence of other growth factors. To determine which lymphokines present in the activated lesional T cell supernatants are critical for the observed enhancement of keratinocyte stem cell growth by the activated lesional T cell supernatants, we used neutralizing antibodies against IL-3, GM-CSF, and y-IFN. Each antibody, or its isotype control, was added to the T cell supernatant to block the effect of these individual lymphokines in the 72-h short-term psoriatic uninvolved epidermal cell culture assay. The neutralizing antibody concentrations were calculated to achieve a 100-fold excess of neutralizing activity based upon the known amounts of lymphokines in the supernatants and the neutralizing activity of each antibody. In each of four experiments anti-y-IFN neutralization resulted in inhibition of keratinocyte growth, with a 39±7.7% inhibition of /1 integrinb rght cell numbers and a 34±6.3% inhibition in the numbers of S/ G2/M phase /31 integrinb1ight cells, relative to isotype control cultures (Fig. 8) . Addition of anti-y-IFN to the cultures did not influence the number and proliferation of vimentin+ cells, indicating that keratinocytes are a specific target of growth stimulation by y-IFN (data not shown).
No consistent growth inhibition was observed upon addition of either anti-GM-CSF or anti-IL-3 (Fig. 8) . Addition of the neutralizing anti-GM-CSF and anti-IL-3 to the epidermal cell cultures without the growth-promoting supernatant 4F4 also did not influence keratinocyte stem cell growth, suggesting that autocrine production of these lymphokines was not responsible for growth regulation. Addition of neutralizing antibody against TNF-a also did not affect keratinocyte stem cell growth (data not shown). (45) . However, when placed into culture, label-retaining cells thought to be epidermal stem cells are known to be actively cycling and clonogenic (35, 46 (30) or recombinant lymphokines (47) (48) (49) .
Although both IL-3 and GM-CSF seem to be growth-promoting factors for keratinocytes in vivo (50) (51) (52) as well as in vitro on passaged cells (47) , our neutralization experiments in the short-term primary culture model suggest that y-IFN, and not GM-CSF or IL-3, is a potent stimulatory cofactor in psoriatic uninvolved keratinocyte stem cell proliferation. y-IFN has been reported to inhibit normal, and to a lesser degree, psoriatic, epidermal cell growth in vitro in primary cultures (48, 49), despite its ability to induce TGFa (53). We have observed a similar result in our stem cell growth assay. However, y-IFN administered in vivo to psoriatic uninvolved skin resulted in hyperproliferation of the epidermis (54) . It is possible that in vivo growth factors (such as GM-CSF, IL-3, or other factors) are sufficiently present in the epidermis to provide the necessary costimulatory signals for y-IFN to become growth stimulatory. Similar to our observation on psoriatic uninvolved keratinocyte stem cells, y-IFN also exhibits a growth-promoting effect on hemopoietic progenitor cells in the presence of GM-CSF and IL-3 (55) .
The observed hyperresponsiveness of psoriatic uninvolved f31 integrin+ Kl/K10-keratinocytes to the growth-promoting effect of T cell lymphokines relative to normal keratinocytes is of particular interest. The hyperresponsive status of uninvolved psoriatic stem cells can either be the result of genetic susceptibility or the result of a chronic low grade stimulatory priming of the keratinocytes in vivo. These in vitro data correspond to the clinical observations that, although epidermal hyperplasia occurs in a variety of skin conditions containing activated T cells (56) (57) (58) , the most significant hyperproliferation occurs in psoriasis. The finding is also consistent with the Kobner phenomenon, in which inflammation or wounding of psoriatic uninvolved skin can result in development of a psoriatic lesion in the presence of an epidermal infiltrate dominated by CD4 + T cells (59) , whereas similar perturbation of normal skin does not result in such changes.
In conclusion, these data characterize a sensitive in vitro model of T cell and keratinocyte stem cell growth regulatory interactions that appears highly relevant to the human skin disease, psoriasis. According to this model, lesional CD4 + T cells, through the release of y-IFN in the context of other cytokines, act on resting 6l1 integrin+ Ki/KlO-vimentin-keratinocyte stem cells to enter cell cycle (PCNA +) and subsequently progress through S/G2/M, resulting in expansion of the proliferative compartment population. This model may be useful in understanding regulation of epidermopoiesis and in determining specific markers of genetic susceptibility to psoriasis.
